BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8533127)

  • 1. Reduction of platelet surface GPIb expression induced by polymorphonuclear leukocytes.
    Schattner M; Kempfer A; Geffner J; Bermejo E; Frontroth JP; Lazzari M
    Thromb Res; 1995 Aug; 79(3):319-24. PubMed ID: 8533127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
    Kasirer-Friede A; Frojmovic MM
    Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation.
    Cramer EM; Lu H; Caen JP; Soria C; Berndt MC; Tenza D
    Blood; 1991 Feb; 77(4):694-9. PubMed ID: 1825180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human platelet activation by polymorphonuclear leukocytes.
    Schattner MA; Geffner JR; Isturiz MA; Lazzari MA
    Br J Pharmacol; 1990 Oct; 101(2):253-6. PubMed ID: 2257433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ristocetin-induced platelet agglutination stimulates GPIIb/IIIa-dependent calcium influx.
    Bertolino G; Noris P; Spedini P; Balduini CL
    Thromb Haemost; 1995 Apr; 73(4):689-92. PubMed ID: 7495080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ascorbic acid in the modulation of inhibition of platelet aggregation by polymorphonuclear leukocytes.
    Raghavan SA; Sharma P; Dikshit M
    Thromb Res; 2003 May; 110(2-3):117-26. PubMed ID: 12893026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate-intensity exercise suppresses platelet activation and polymorphonuclear leukocyte interaction with surface-adherent platelets under shear flow in men.
    Wang JS; Liao CH
    Thromb Haemost; 2004 Mar; 91(3):587-94. PubMed ID: 14983236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of platelet glycoprotein Ib by elastase released from primed neutrophils.
    Aziz KA; Cawley JC; Kamiguti AS; Zuzel M
    Br J Haematol; 1995 Sep; 91(1):46-54. PubMed ID: 7577651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib.
    Walsh MT; Dinan TG; Condren RM; Ryan M; Kenny D
    Life Sci; 2002 May; 70(26):3155-65. PubMed ID: 12008098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils.
    Taylor ML; Ilton MK; Misso NL; Watkins DN; Hung J; Thompson PJ
    Br J Clin Pharmacol; 1998 Aug; 46(2):139-45. PubMed ID: 9723822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic peripheral arterial occlusive disease, platelet glycoproteins GPIIb-IIIa and GP Ib-IX, plasma von Willebrand factor and plasma fibrinogen concentrations in patients with type 2 diabetes mellitus].
    Gosk-Bierska I; Adamiec R; Doskocz W; Ciosek W
    Pol Arch Med Wewn; 2000; 103(3-4):139-45. PubMed ID: 11236240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIba.
    Pontiggia L; Steiner B; Ulrichts H; Deckmyn H; Forestier M; Beer JH
    Thromb Haemost; 2006 Dec; 96(6):774-80. PubMed ID: 17139372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control study of platelet glycoprotein receptor Ib and IIb/IIIa expression in patients with acute and chronic cerebrovascular disease.
    Kraft P; Drechsler C; Gunreben I; Heuschmann PU; Kleinschnitz C
    PLoS One; 2015; 10(3):e0119810. PubMed ID: 25748430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release.
    Mousa SA; Bozarth J; Forsythe M; Tsao P; Pease L; Reilly TM
    Life Sci; 1994; 54(16):1155-62. PubMed ID: 8152339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
    Danton MC; Zaleski A; Nichols WL; Olson JD
    J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibalpha is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathway.
    Marshall SJ; Asazuma N; Best D; Wonerow P; Salmon G; Andrews RK; Watson SP
    Biochem J; 2002 Jan; 361(Pt 2):297-305. PubMed ID: 11772401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.